Diagnostic implications and inpatient mortality related to tuberculosis at Jimma Medical Center, southwest Ethiopia

• Published in: Journal of clinical tuberculosis and other mycobacterial diseases Vol. 23; p. 100220
• Main Authors: Kebede, Wakjira, Gudina, Esayas Kebede, Balay, Getu, Abebe, Gemeda
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.05.2021; Elsevier
• Subjects: Diagnosis; Ethiopia; HIV; Mortality; Tuberculosis; Tuberculosis; Diagnosis; HIV; Mortality; Ethiopia
• ISSN: 2405-5794; 2405-5794
• DOI: 10.1016/j.jctube.2021.100220

Tuberculosis (TB) is one of the major public health problems in Ethiopia. Determining discharge outcome of TB cases helps to understand the effectiveness of TB diagnosis effort to improve case management. The objective of this study was to assess discharge outcomes and factors associated with death among patients on TB treatment admitted to a referral hospital in southwest Ethiopia. A retrospective study was conducted at Jimma Medical Center by reviewing medical records of TB patients (age ≥15 years) admitted to medical wards from January 2015 to December 2017. Demographic and related data was collected using data collection format. The clinical evaluation outcome of an individual patient at discharge was recorded. Descriptive statistics were used to summarize participant characteristics. Multivariate logistic regression analyses were used to evaluate the risk factors for TB mortality. Among 465 patients included in the review, 225 (48.4%) were pulmonary (PTB) and 240 (51.6%) extra-pulmonary TB (EPTB) cases. Overall, 190 (40.9%) had bacteriologically confirmed for TB. HIV status was documented for 340 (73.1%) of them; 93 (27.4%) were found to be positive. The prevalence of HIV infection among EPTB and PTB cases was 50/275 (18.2%) and 43/190 (22.8%), respectively. A quarter of the patient, 114 (24.5%), died in the hospital while the rest were discharged with clinical improvement. Compared to smear positive PTB, the risk of death was two times higher in patients with smearnegative PTB cases (aOR 2.3, 95% CI: 1.3–4.2). TB patients with chronic obstructive pulmonary disease (COPD) (aOR 4.6, 95% CI: 1.3–16.7), diabetes mellitus (aOR 5.7, 95% CI: 1.5–23.7), heart disease (aOR 3.8, 95% CI: 1.4–10.4) had about four-fold increased risk of death. HIV-positive patients had a higher risk of death (aOR 2.9, 95% CI: 1.7–5.0) than HIV-negative patients. The risk of death was not affected by the type of TB diagnosed, as 27.6% ofEPTBand 31.9% PTB were died (p = 0.457). TB was associated with high inpatient mortality at Jimma Medical Center. Mortality was found to be higher among unconfirmed cases, those with COPD, diabetes mellitus, heart disease and HIV infection. Thus, any effort to curtail mortality in such high TB burden setting should focus on improving TB diagnosis and addressing major comorbid medical conditions.